Printer Friendly
The Free Library
22,728,043 articles and books

HIV is double trouble for brain.



People who live a long time while infected with HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  sometimes develop dementia. The virus that causes AIDS is known to damage brain cells, and it now appears that the virus halts the creation of new neurons as well.

A single protein in the virus' outer shell triggers both dementia-inducing effects, new research shows. Brains normally generate a steady stream of new nerve cells in the hippocampus hippocampus

fabulous marine creature; half fish, half horse. [Rom. Myth. and Art: Hall, 154]

See : Monsters
, a region associated with learning. But the HIV protein called gp120 inhibits the stem cells in the brain from producing new nerve cells.

However, "there is a silver lining to this," says research leader Stuart A. Lipton of the University of California, San Diego UCSD is consistently ranked among the top ten public universities for undergraduate education in the United States by U.S. News & World Report.[3] It is a Public Ivy. [1] For graduate studies, most of UCSD's Ph.D. . That's because gp120's ability both to kill mature brain cells and to hinder the birth of new ones depends on a single brain-cell enzyme. This enzyme, called p38 mitogen-activated protein kinase Mitogen-activated protein (MAP) kinases (EC 2.7.11.24) are serine/threonine-specific protein kinases that respond to extracellular stimuli (mitogens) and regulate various cellular activities, such as gene expression, mitosis, differentiation, and cell survival/apoptosis.  (MAPK MAPK Mitogen-Activated Protein Kinase
MAPK Map Kinase
), could provide a target for drugs against the dementia.

"If you can inhibit that enzyme, you might be able to reduce the brain damage," Lipton says. Drugs that block MAPK are currently in late-stage clinical trials for treating arthritis.

Lipton's team had previously demonstrated gp120's lethal effect on mature neurons by injecting it into mice. In the new research, reported in the August Cell Stem Cell, mice getting such injections ended up with few stem cells, which appeared not to be dividing.--P.B.
COPYRIGHT 2007 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:NEUROSCIENCE
Publication:Science News
Date:Sep 8, 2007
Words:227
Previous Article:A different view of Uranus' rings.
Next Article:Men's fertile role in evolving long lives.



Related Articles
The new nannies.
The change of autumn is in the air.
Chapter meetings.
THE 'INFAMOUS 15' WEIGHS HEAVILY OVER INCOMING COLLEGE FRESHMEN.
BODY > BEAUTIFUL ON THE OUTSIDE.
Tooling around the pro-am 'chop' shop inspires swing thoughts.
FAMILIES LOSING HOMES HOUSING IN VALLEY REFLECTS TROUBLES FORECLOSURES SOAR NEARLY 400 PERCENT.
Live wires: axons can influence nerve impulses.
Aura origins show the way in epilepsy surgery.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters